Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | SA4C9 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z007581 | — |
No additional AE reported. No PQC reported.; Nurse reports she administered both PROQUAD and PRIORIX to an adult male patient today 3/20/2026. No additional AE details provided. Nurse consents to follow-up. No additional AE reported. No PQC reported.; This spontaneous report was received from a nurse and refers to a male patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications were not reported. On 20-Mar-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Lot No. Z007581 has been verified to be a valid lot number, expiration date: 12-Oct-2026, administered for prophylaxis (dose, route of administration and anatomical site of injection were not provided). The vaccine was reconstituted with sterile diluent (BAXTER Sterile Diluent), (indication, expiration date, and lot # were not reported). On that same date, the patient was also vaccinated with Measles vaccine live (Schwartz);Mumps vaccine live (RIT 4385);Rubella vaccine live (Wistar RA 27/3)) (PRIORIX) (lot #SA4C9, expiration date: 01-Mar-2027) (overdose). No additional adverse event was reported (no adverse event).
DILUENT MRK